(Q44132304)

30 November 2017

Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1. (English)

1 reference

30 November 2017

Ravi B Marala

1

1 reference

30 November 2017

Janice A Brown

2

1 reference

30 November 2017

Jimmy X Kong

3

1 reference

30 November 2017

W Ross Tracey

4

1 reference

30 November 2017

Delvin R Knight

5

1 reference

30 November 2017

Ronald T Wester

6

1 reference

30 November 2017

Dexue Sun

7

1 reference

30 November 2017

Scott P Kennedy

8

1 reference

30 November 2017

Ernest S Hamanaka

9

1 reference

30 November 2017

Roger B Ruggeri

10

1 reference

30 November 2017

Roger J Hill

11

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

European Journal of Pharmacology

30 November 2017

1 reference

30 November 2017

451

1 reference

30 November 2017

1

1 reference

30 November 2017

37-41

1 reference

(2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Molecular cloning, sequencing, tissue distribution, and functional expression of a Na+/H+ exchanger (NHE-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H+ exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

New Na(+)-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Comparative effects of Na+/H+ exchange inhibitors against cardiac injury produced by ischemia/reperfusion, hypoxia/reoxygenation, and the calcium paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Na+/H+ exchangers. Molecular diversity and relevance to heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Molecular physiology of vertebrate Na+/H+ exchangers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

Na+-H+ exchange in isolated myocytes from adult rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902193-3

10.1016/S0014-2999(02)02193-3

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference